Laura De Marchis | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study	JAMA	2024
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study	CANCER	2024
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers	ANNALS OF ONCOLOGY	2024
Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study	CANCER	2024
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers	ANNALS OF ONCOLOGY	2024
Heterozygous Pathogenic Nonsense Variant in the ATM Gene in a Family with Unusually High Gastric Cancer Susceptibility	BIOMEDICINES	2023
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants	NPJ BREAST CANCER	2021
Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer	ESMO OPEN	2021
Opioids and breast cancer recurrence: a systematic review	CANCERS	2021
Spectrum of germline BRCA1 and BRCA2 variants identified in 2351 ovarian and breast cancer patients referring to a reference cancer hospital of Rome	CANCERS	2020
Beyond BRCA1 and BRCA2: deleterious variants in DNA repair pathway genes in italian families with breast/ovarian and pancreatic cancers	JOURNAL OF CLINICAL MEDICINE	2020
Pregnancy after breast cancer in patients with germline BRCA mutations	JOURNAL OF CLINICAL ONCOLOGY	2020
Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline	ONCOTARGET	2018
Blood and sputum biomarkers in COPD and asthma: a review	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES	2016

Gruppi di ricerca

VALORE PROGNOSTICO DELLE VARIANTI PATOGENETICHE DI GENI DDR (DNA DAMAGE REPAIR) NEI PAZIENTI CON NUOVA DIAGNOSI DI CARCINOMA PROSTATICO O DI NEOPLASIE DELLO STOMACO, PANCREAS E VIE BILIARI: IMPLICAZIONI DELL’ANALISI EREDO-FAMILIARE